Julian Adams Insider Profile

4 Followers
Julian Adams, President of R&D at Infinity Pharma, holds 235.31K shares in Infinity Pharma (Ticker: INFI), holds ― shares in Pieris Pharmaceuticals (Ticker: PIRS).
tipranks
Julian Adams

Julian Adams
Infinity Pharma (INFI)
President of R&D

Not Ranked
Julian Adams has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$471K
100.00%
0.00%
A breakdown of Julian Adams's holdings

Insider Roles

Infinity Pharma
(INFI)
President of R&D
Pieris Pharmaceuticals
(PIRS)
Director
Roles that Julian Adams holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Julian Adams

Julian Adams's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Infinity Pharma
Nov 02, 2016
President of R&D
Uninformative Buy
$470.63K
Pieris Pharmaceuticals
Director
List of latest transactions for each holding click on a transaction to see Julian Adams's performance on stock

Julian Adams insider profile FAQ

What is the percentage of profitable transactions made by Julian Adams?
The percentage of profitable transactions made by Julian Adams is ―.
    What is the average return per transaction made by Julian Adams?
    The average return per transaction made by Julian Adams is ―.
      What stocks does Julian Adams hold?
      Julian Adams holds: INFI, PIRS stocks.
        What was Julian Adams’s latest transaction?
        Julian Adams latest transaction was an Uninformative Buy of ―.
          What was Julian Adams's most profitable transaction?
          Julian Adams’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Julian Adams's role in Infinity Pharma?
            Julian Adams's role in Infinity Pharma is President of R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.